A Phase ??, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JMT202 Injection in Chinese Healthy Participants
Latest Information Update: 27 Aug 2024
At a glance
- Drugs JMT 202 (Primary)
- Indications Hypertriglyceridaemia
- Focus Adverse reactions
- Sponsors Shanghai JMT-BIO Technology
Most Recent Events
- 27 Aug 2024 New trial record